Picture of Ultralife logo

ULBI — Ultralife News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapNeutral

Ultralife Corp reports results for the quarter ended in March - Earnings Summary

* Ultralife Corp  ULBI.OQ  reported quarterly adjusted
earnings of
21 cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -1
cents.  The lone analyst forecast for the quarter was
for earnings of 10 cents per share. 
    * Revenue rose 31.4% to $41.93 million from a year ago;
analysts
expected $38.00 million. 
    * Ultralife Corp's reported EPS for the quarter was 18
cents​.
    * The company reported quarterly net income of $2.89
million.
    * Ultralife Corp shares had fallen by 0.9% this quarter and
gained 28.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the electrical
components & equipment peer group is also "buy"

Wall Street's median 12-month price target for Ultralife Corp is
$12.00 
This summary was machine generated from LSEG data April 25 at
02:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.10           0.21           Beat
                                  0.18           
 Sep. 30 2023      0.10           0.10           Met
 Jun. 30 2023      0.04           0.29           Beat

Recent news on Ultralife

See all news